TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2025-01-30
Target enrollment:
Participant gender:
Summary
A phase 1 dose escalation and expanded cohort study of TR115 in the treatment of adult
patients with relapsed/refractory non-hodgkin's lymphoma or advanced solid tumors.